AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NEW YORK -- Duane Reade has agreed to lower its sale price to $16.50 per share from $17 per share, the Manhattan-based drug chain announced on Monday.
The deal is now worth about $403.8 million. The transaction is subject to, among other things, approval by Duane Reade's stockholders. A stockholders' meeting is scheduled for July 26.
As previously reported, Oak Hill had requested that the $17 per share …